1. Protective immune responses in guinea pigs and swine induced by a suicidal DNA vaccine of the capsid gene of swine vesicular disease virus.
- Author
-
Sun SQ, Liu XT, Guo HC, Yin SH, Shang YJ, Feng X, Liu ZX, and Xie QG
- Subjects
- Animals, Capsid Proteins genetics, Cell Line, Cell Proliferation, Cricetinae, Genetic Vectors, Guinea Pigs, Immunization, Secondary, Lymphocyte Activation, Lymphocytes immunology, Neutralization Tests, Plasmids genetics, Semliki forest virus genetics, Swine, Swine Vesicular Disease prevention & control, Antibodies, Viral blood, Capsid Proteins immunology, Enterovirus B, Human immunology, Vaccines, DNA immunology, Viral Vaccines immunology
- Abstract
A suicidal DNA vaccine based on a Semliki Forest virus (SFV) replicon was evaluated for the development of a vaccine against swine vesicular disease virus (SVDV). The 1BCD gene of SVDV was cloned and inserted into pSCA1, an SFV DNA-based replicon vector. The resultant plasmid, pSCA/1BCD, was transfected into BHK-21 cells and the antigenicity of the expressed protein was confirmed using an indirect immunofluorescence assay. Immunogenicity was studied in guinea pigs and swine. Animals were injected intramuscularly three times with pSCA/1BCD at regular intervals. Anti-SVDV antibodies were detected by ELISA, the lymphocyte proliferation response was tested by the 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide method and neutralizing antibodies were measured by microneutralization tests. The data showed that SVDV-specific antibodies, neutralizing antibodies and lymphocyte proliferation were induced in both guinea pigs and swine. Furthermore, after three successive vaccinations with pSCA/1BCD, half of the pigs were protected against challenge with SVDV. These results should encourage further work towards the development of a DNA vaccine against SVDV.
- Published
- 2007
- Full Text
- View/download PDF